This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_URETER_EXALLC for full statistics.
Malignant neoplasm of ureter
C3_URETER
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
83 |
4. Check minimum number of eventsNone |
83 |
5. Include endpointsNone |
83 |
6. Filter based on genotype QC (FinnGen only) |
83 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of ureter
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of urinary organs
- Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 83 | 28 | 55 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | 73.85 | 73.22 | 74.17 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 74
- Matched controls
- 738
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C66
ICD-10 Finland
Malignant neoplasm of ureter
4518.8
82.4
64
*
8120/3-C66.9
ICD-O-3
Transitional cell carcinoma, NOS, of ureter
+∞
80.6
62
*
UKC02
NOMESCO Finland
Cystoscopy
54.5
40.7
67
110
UKB02
NOMESCO Finland
Retrograde ureteroscopy
276.6
33.8
32
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
97.0
31.4
33
6
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
57.9
28.7
33
10
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
370.0
26.5
25
*
KAC20
NOMESCO Finland
Nephroureterectomy
370.0
26.5
25
*
R31
ICD-10 Finland
Unspecified haematuria
16.4
24.3
46
67
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
46.6
19.4
23
7
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
34.6
18.8
24
10
KCD02
NOMESCO Finland
Transurethral resection of bladder
25.9
18.7
26
15
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
100.3
15.2
16
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
35.8
15.2
19
7
TPH07
NOMESCO Finland
Cathetrisation of artery
9.5
12.4
27
42
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
11.5
10.6
20
23
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
24.2
10.3
14
7
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
10.5
10.2
20
25
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
114.0
9.7
10
*
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
114.0
9.7
10
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
11.9
9.4
17
18
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
+∞
8.5
8
*
KBD00
NOMESCO Finland
Partial excision of ureter
+∞
8.5
8
*
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
25.4
8.3
11
5
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
25.4
8.3
11
5
KH1AD
NOMESCO Finland
CT of urinary organs
17.6
8.0
12
8
130
Kela drug reimbursment
Malignant tumour
6.6
7.9
21
42
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
50.5
7.9
9
*
KBH20
NOMESCO Finland
Replantation of ureter
+∞
7.4
7
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
11.0
7.1
13
14
WX408
NOMESCO Finland
General anesthesy, balanced
4.3
7.1
31
107
WX402
NOMESCO Finland
General anaesthesia
5.6
7.0
21
49
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.8
6.8
24
67
B01AB05
ATC
enoxaparin; parenteral
3.8
6.7
36
147
ZXE00
NOMESCO Finland
One hour or less
3.5
6.3
40
186
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.4
6.1
23
68
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3049717) Cytology report of Urine Cyto stain
52
31
43.23
68.62
5.9
2.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
56
255
4.68
10.43
7.4
3.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
48
220
3.80
8.31
6.5
3.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
17
38
5.37
7.58
11.4
7.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
37
150
3.65
7.58
6.0
2.9
e6/l
3.5
4.4
0.44
32
134
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
53
272
3.62
7.47
6.6
3.7
—
—
—
0
0
(3026782) Osmolality of Urine
36
146
3.59
7.33
5.6
3.2
mosm/kgh2o
466.0
544.7
1.93
30
125
(3030467) Casts [#/volume] in Urine by Automated count
43
199
3.41
7.05
7.7
3.3
e6/l
0.3
0.3
0.03
36
149
(3002582) Erythrocytes [#/volume] in Urine
46
222
3.40
7.04
8.5
3.4
e6/l
562.1
339.4
0.19
40
174
(36304419) Bacteria [Presence] in Urine
40
187
3.20
6.30
7.6
3.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
48
250
3.18
6.27
9.3
4.1
e6/l
154.3
63.7
0.77
42
186
(40768804) Tissue Pathology biopsy report
46
240
3.06
5.89
3.2
2.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
32
140
3.09
5.52
2.9
2.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
65
430
3.36
5.18
8.4
4.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
56
346
2.90
4.96
9.1
5.6
mmol/l
1.2
1.2
0.36
49
284
(3002256) Pathology report gross observation
22
82
3.29
4.90
2.0
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
39
201
2.77
4.89
3.1
2.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
40
213
2.69
4.66
6.3
4.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
18
61
3.49
4.62
10.6
7.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
25
107
2.91
4.37
5.6
2.6
mmol/l
0.8
0.8
0.33
25
95
(1616796) Gas panel - Central venous blood
8
10
8.70
4.16
6.2
4.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
22
94
2.82
3.82
9.8
5.4
mmol/l
-2.1
1.3
2.13
16
79
(3032080) INR in Blood by Coagulation assay
48
299
2.44
3.81
17.5
9.2
inr
1.3
1.4
0.16
15
86
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
25
117
2.63
3.64
8.0
3.1
e6/l
0.8
1.5
0.47
18
65
(3018418) pH of Serum or Plasma
37
211
2.36
3.52
6.3
4.4
ph
7.4
7.4
—
8
46
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
25
121
2.53
3.38
7.2
3.0
e6/l
1.3
1.2
0.06
17
69
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
52
354
2.26
3.14
10.2
5.5
umol/l
9.4
11.8
2.14
52
329
(40761535) Cells panel - Urine sediment
13
51
2.84
2.59
4.3
3.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
49
350
1.98
2.34
12.7
9.0
e9/l
4.2
4.3
0.11
39
301
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
70
573
2.42
2.27
28.7
17.4
mg/l
48.7
28.4
3.06
64
478
(3035637) Corticotropin [Mass/volume] in Plasma
5
9
5.83
2.24
1.2
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
35
227
1.94
2.18
5.3
3.5
mmol/l
2.3
2.3
0.00
30
193
(3021601) Nitrite [Presence] in Urine by Test strip
43
301
1.89
2.12
8.0
6.2
estimate
0.0
0.0
—
9
59
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
11
44
2.73
2.11
4.0
2.6
mmol/l
2.5
1.8
—
5
33
(3052851) Hemolysis interference index of Serum or Plasma
7
20
3.72
2.10
5.6
3.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
43
304
1.86
2.03
6.1
4.6
estimate
0.0
0.0
—
10
56
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
24
140
2.00
2.00
3.4
3.2
mmol/l
2.5
2.5
0.01
17
124
(3035350) Ketones [Presence] in Urine by Test strip
43
305
1.85
2.00
6.0
4.6
estimate
0.0
0.0
—
10
62
(40761511) CBC panel - Blood by Automated count
69
580
2.12
1.80
27.7
16.5
—
—
—
0
0
(4035726)
13
62
2.30
1.76
1.8
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
13
4.02
1.74
2.2
2.5
—
—
—
0
0
(3015736) pH of Urine
34
238
1.73
1.57
5.3
4.5
—
—
—
0
0
(3013512) EKG study
31
212
1.74
1.55
4.7
4.9
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
6
21
3.00
1.53
4.8
2.0
mmol/l
23.7
24.4
—
6
14
(3006504) Eosinophils/100 leukocytes in Blood
38
278
1.68
1.47
4.7
5.5
%
2.5
2.6
0.09
33
258
(3036481) Cortisol [Moles/volume] in Serum or Plasma
12
60
2.17
1.46
7.4
2.0
nmol/l
436.2
405.9
0.19
12
54
(3001604) Monocytes [#/volume] in Blood
40
297
1.67
1.46
4.8
5.2
e9/l
0.7
0.6
0.42
31
253
(3021901) Oxygen saturation in Capillary blood
5
16
3.25
1.46
5.2
2.0
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
18
106
1.89
1.44
1.8
1.8
s
30.9
29.5
0.54
18
101
(3006315) Basophils [#/volume] in Blood
40
298
1.66
1.44
4.7
5.2
e9/l
0.0
0.0
0.08
33
256
(3009542) Hematocrit [Volume Fraction] of Blood
57
467
1.70
1.41
31.1
19.5
%
34.7
38.6
2.06
32
288
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
13
70
2.02
1.33
3.5
2.7
umol/l
5.5
10.2
1.19
13
61
(3019198) Lymphocytes [#/volume] in Blood
40
303
1.62
1.32
4.8
5.3
e9/l
1.6
1.7
0.22
31
266
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
32
230
1.64
1.30
7.4
5.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
25
170
1.67
1.24
6.2
2.9
u/l
34.6
32.1
0.16
25
157
(3013115) Eosinophils [#/volume] in Blood
40
308
1.58
1.21
4.8
5.5
e9/l
0.2
0.2
0.35
32
266
(3007461) Platelets [#/volume] in Blood
70
619
1.84
1.18
42.9
25.3
e9/l
248.3
231.8
0.94
65
602
(40768443) Skin Pathology biopsy report
0
36
0.00
1.17
0.0
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
70
620
1.82
1.16
43.0
25.4
e12/l
4.2
4.4
2.17
65
601
(3010813) Leukocytes [#/volume] in Blood
70
620
1.82
1.16
43.0
25.3
e9/l
7.3
6.8
1.28
65
599
(3030981) Hyaline casts [#/volume] in Urine by Automated count
9
47
2.02
1.06
7.8
3.5
e6/l
0.2
0.1
—
9
47
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13
76
1.84
1.06
7.8
3.8
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
19
125
1.67
1.06
2.3
2.4
umol/l
10.4
12.6
0.62
19
107
(3017143) Hepatitis C virus Ab [Presence] in Serum
9
48
1.98
1.04
1.6
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
24
170
1.58
1.00
7.0
4.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
0
28
0.00
1.00
0.0
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
9
51
1.86
0.98
1.6
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
10
56
1.89
0.92
4.3
3.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
62
549
1.51
0.84
33.2
17.0
ml/min/173m2
53.4
71.7
8.01
52
446
(3012544) pH of Venous blood
11
66
1.77
0.83
2.8
3.9
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
6
33
1.88
0.81
1.7
2.8
%
0.6
0.7
—
6
33
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
33
1.88
0.81
1.7
2.8
%
0.7
0.9
—
6
33
(40761536) Microorganisms panel - Urine sediment
9
53
1.78
0.79
9.4
4.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
14
93
1.61
0.75
1.3
3.1
%
1.7
1.8
0.20
14
80
(1761868) Lipid panel - Serum or Plasma
11
165
0.62
0.72
4.3
3.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
12
78
1.63
0.70
1.3
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
34
277
1.39
0.69
1.8
2.2
pmol/l
95.9
92.0
0.15
15
130
(3029937) Albumin [Presence] in Urine by Test strip
23
175
1.43
0.68
7.5
4.7
estimate
0.0
0.0
—
7
56
(40768797) Stomach Pathology biopsy report
6
101
0.56
0.67
3.0
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
28
1.83
0.67
1.6
2.1
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
66
603
1.46
0.65
42.1
20.7
umol/l
117.2
86.2
3.23
66
603
(3011397) Hemoglobin [Presence] in Urine by Test strip
19
142
1.44
0.61
4.7
4.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
0
20
0.00
0.61
0.0
1.5
—
31.8
—
0
15
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
20
0.00
0.61
0.0
1.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
0
22
0.00
0.60
0.0
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
23
0.00
0.59
0.0
1.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
25
198
1.38
0.59
3.1
4.0
mg/mmol
5.5
7.7
0.40
20
125
(3022313) Gas panel - Capillary blood
6
35
1.77
0.59
2.7
2.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
9
59
1.59
0.57
2.0
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
18
136
1.41
0.55
1.4
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
23
182
1.36
0.54
2.0
3.1
mmol/l
6.7
7.4
0.44
18
147
(3005719) IgG [Mass/volume] in Serum or Plasma
6
39
1.58
0.54
3.3
2.6
g/l
15.2
9.8
—
6
32
(3004789) Transferrin [Mass/volume] in Serum or Plasma
15
110
1.44
0.53
2.5
2.6
g/l
2.1
2.3
0.46
15
98
(3021589) Normoblasts [#/volume] in Blood
32
268
1.32
0.52
20.9
11.2
e9/l
0.0
0.0
0.71
21
223
(3019225) pH of Specimen
10
67
1.56
0.52
3.3
2.9
—
—
—
0
0
(3044889) 12 lead EKG panel
48
427
1.29
0.50
4.8
4.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
23
185
1.34
0.49
2.0
3.1
mg/l
24.1
407.4
0.57
16
117
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
7
48
1.50
0.48
6.3
4.6
mmol/l
23.3
24.4
—
7
48
(3007853) Bacteria identified in Skin by Aerobe culture
10
69
1.51
0.47
1.3
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
17
134
1.34
0.41
7.1
5.3
kg/l
1.0
1.0
—
6
18
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.2
—
0.2
—
0
17
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.3
—
1.2
—
0
18
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
5
35
1.46
0.40
5.6
2.7
u/ml
17.8
121.5
—
5
27
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
25
211
1.26
0.37
3.9
5.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
6
41
1.50
0.37
1.0
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
14
109
1.34
0.36
6.0
5.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
11
82
1.39
0.36
1.5
1.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
51
1.41
0.32
1.3
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
21
177
1.25
0.31
2.1
3.1
umol/l
373.5
9848.6
1.26
15
139
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
14
116
1.25
0.24
1.7
1.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5
38
1.34
0.23
1.2
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
5
39
1.30
0.23
1.0
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.9
—
15.7
—
0
10
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
9.3
—
0
12
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
12
0.00
0.21
0.0
3.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
12
0.00
0.21
0.0
2.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
3.5
—
76.2
—
0
12
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
52
548
0.86
0.21
4.1
4.9
mmol/l
4.3
4.4
0.27
45
493
(40768793) Breast Pathology biopsy report
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
20
176
1.18
0.20
2.2
3.1
ug/l
0.7
0.8
0.21
13
124
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
28
254
1.15
0.19
2.1
2.3
nmol/l
83.8
76.1
0.40
22
216
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
52
546
0.87
0.19
4.1
4.9
mmol/l
1.3
1.4
0.55
45
482
(3004588) Protein electrophoresis panel - Serum or Plasma
7
61
1.16
0.18
4.0
2.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
8
68
1.20
0.17
1.5
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
54
564
0.88
0.17
4.8
5.5
mmol/l
2.4
2.5
0.61
48
501
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
76
0.77
0.16
11.7
10.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
54
517
1.13
0.15
5.8
4.9
mu/l
1.9
2.0
0.32
49
448
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
24
262
0.88
0.15
1.9
2.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
17
152
1.15
0.13
9.3
7.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
5
47
1.07
0.09
2.8
2.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
7
63
1.12
0.08
1.6
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
20
187
1.09
0.07
1.5
2.1
u/l
334.1
294.5
0.06
20
179
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
25
238
1.07
0.06
3.3
4.5
%
19.2
21.5
0.42
13
125
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
52
531
0.94
0.04
3.7
4.3
mmol/l
1.3
1.2
0.89
45
466
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
14
131
1.08
0.04
1.5
1.7
mg/l
1.8
1.5
—
9
98
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
56
551
1.05
0.03
5.5
5.4
mmol/l
6.1
6.2
0.21
49
491
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
53
538
0.96
0.02
7.4
6.6
mmol/mol
41.8
41.6
0.07
48
492
(3042936) Bacteria identified in Isolate by Culture
10
93
1.09
0.02
2.1
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
8
0.00
0.00
0.0
3.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.3
—
210.6
—
0
7
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
4.8
—
57.2
—
0
5
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
43.1
—
0
5
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
104.4
—
0
7
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
2.7
—
23.2
—
0
9
(3037522) Nuclear Ab [Titer] in Serum
6
60
1.00
0.00
1.2
1.5
—
264.6
—
0
13
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4146454)
0
8
0.00
0.00
0.0
3.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
8
0.00
0.00
0.0
4.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
18.9
—
0
6
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_URETER – Malignant neoplasm of ureter
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).